Close

Ratings by JPMorgan (Jessica Fye)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/8/2022 Nektar Therapeutics NKTR Downgrade Underweight
(Neutral)
4.42
(3.20)
-27.6% Details
8/2/2022 Vertex VRTX New Coverage Overweight
(N/A)
280.41
(289.54)
3.26% Details
8/2/2022 Seagen SGEN New Coverage Overweight
(N/A)
179.98
(136.83)
-23.97% Details
8/2/2022 NovoCure Ltd. NVCR New Coverage Neutral
(N/A)
67.99
(75.98)
11.75% Details
8/2/2022 Moderna MRNA New Coverage Neutral
(N/A)
164.09
(118.25)
-27.94% Details
8/2/2022 Legand Biotech Corp. LEGN New Coverage Overweight
(N/A)
47.24
(40.80)
-13.63% Details
8/2/2022 Karuna Therapeutics Inc. KRTX New Coverage Overweight
(N/A)
130.25
(224.93)
72.69% Details
8/2/2022 Incyte INCY New Coverage Neutral
(N/A)
77.68
(66.64)
-14.21% Details
8/2/2022 Cerevel Therapeutics CERE New Coverage Overweight
(N/A)
26.29
(28.26)
7.49% Details
8/2/2022 BioNTech BNTX New Coverage Neutral
(N/A)
165.15
(134.88)
-18.33% Details
8/2/2022 BioMarin Pharmaceutical Inc. BMRN New Coverage Overweight
(N/A)
86.05
(84.77)
-1.49% Details
8/2/2022 Alkermes ALKS New Coverage Neutral
(N/A)
25.60
(22.33)
-12.77% Details
6/7/2022 Zymeworks ZYME Maintain Neutral
(N/A)
 
 
  Details
6/6/2022 Amarin Corporation AMRN Maintain Underweight
(N/A)
 
 
  Details
5/24/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
5/19/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
5/6/2022 Amarin Corporation AMRN Downgrade Underweight
(Neutral)
1.56
(1.09)
-30.13% Details
5/5/2022 Esperion Therapeutics ESPR Upgrade Neutral
(Underweight)
6.53
(6.70)
2.6% Details
5/2/2022 Halozyme Therapeutics HALO Maintain Overweight
(N/A)
 
 
  Details
4/20/2022 Lava Therapeutics NV LVTX Maintain Overweight
(N/A)
 
 
  Details
4/19/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
4/13/2022 Zymeworks ZYME Maintain Neutral
(N/A)
 
 
  Details
3/25/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
3/24/2022 Ionis Pharmaceuticals IONS Maintain Neutral
(N/A)
 
 
  Details
3/14/2022 Cara Therapeutics CARA Maintain Overweight
(N/A)
 
 
  Details
3/9/2022 Emergent BioSolutions EBS Maintain Neutral
(N/A)
 
 
  Details
3/8/2022 Cara Therapeutics CARA Upgrade Overweight
(Neutral)
10.70
(9.36)
-12.52% Details
3/1/2022 Nektar Therapeutics NKTR Maintain Neutral
(N/A)
 
 
  Details
2/28/2022 Rubius RUBY Maintain Neutral
(N/A)
 
 
  Details
2/25/2022 United Therapeutics Corp. UTHR Maintain Overweight
(N/A)
 
 
  Details
2/25/2022 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
2/7/2022 Radius Health RDUS Maintain Neutral
(N/A)
 
 
  Details
2/7/2022 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
2/7/2022 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
1/3/2022 Landos Biopharma LABP Maintain Neutral
(N/A)
 
 
  Details
11/22/2021 Stoke Therapeutics STOK Upgrade Overweight
(Neutral)
28.06
(12.84)
-54.24% Details
11/16/2021 Tricida TCDA Upgrade Neutral
(Underweight)
5.46
(10.48)
91.94% Details
11/12/2021 Crinetics CRNX Maintain Overweight
(N/A)
 
 
  Details
9/20/2021 Mirum Pharamceuticals MIRM New Coverage Overweight
(N/A)
18.33
(21.01)
14.62% Details
9/15/2021 Denali Therapeutics Inc. DNLI Maintain Overweight
(N/A)
 
 
  Details
8/20/2021 Aprea APRE Downgrade Underweight
(Neutral)
3.62
(0.65)
-82.04% Details
8/3/2021 Cara Therapeutics CARA New Coverage Neutral
(N/A)
11.97
(9.36)
-21.8% Details
8/3/2021 Magenta Therapeutics MGTA Downgrade Neutral
(Overweight)
7.12
(1.41)
-80.2% Details
7/28/2021 Intra-Cellular Therapies ITCI Maintain Overweight
(N/A)
 
 
  Details
6/23/2021 Jazz Pharmaceuticals JAZZ Maintain Overweight
(N/A)
 
 
  Details
6/18/2021 Crinetics CRNX Upgrade Overweight
(Overweight)
18.50
(19.64)
6.16% Details
6/16/2021 Kaleido Biosciences Inc. KLDO Maintain Underweight
(N/A)
 
 
  Details
5/21/2021 Stoke Therapeutics STOK Maintain
(N/A)
 
 
  Details
5/21/2021 Mersana MRSN Maintain Neutral
(N/A)
 
 
  Details
5/21/2021 Crinetics CRNX Maintain Neutral
(N/A)
 
 
  Details
5/19/2021 Jazz Pharmaceuticals JAZZ New Coverage Overweight
(N/A)
175.09
(133.29)
-23.87% Details
4/19/2021 Lava Therapeutics NV LVTX New Coverage Overweight
(N/A)
15.62
(4.57)
-70.74% Details
3/2/2021 Immunocore Holdings IMCR New Coverage Overweight
(N/A)
48.36
(46.94)
-2.94% Details
3/1/2021 Landos Biopharma LABP New Coverage Neutral
(N/A)
12.99
(0.65)
-95% Details
1/29/2021 Aptinyx APTX Downgrade Underweight
(Neutral)
3.70
(0.37)
-90% Details
1/29/2021 Lexicon Pharmaceuticals LXRX Upgrade Neutral
(Underweight)
8.06
(2.40)
-70.22% Details
10/14/2020 Magenta Therapeutics MGTA New Coverage Overweight
(N/A)
7.67
(1.41)
-81.62% Details
10/14/2020 Crinetics CRNX New Coverage Neutral
(N/A)
16.77
(18.50)
10.32% Details
9/29/2020 Tricida TCDA New Coverage Underweight
(N/A)
8.87
(10.48)
18.15% Details
9/29/2020 Aprea APRE New Coverage Neutral
(N/A)
22.65
(0.65)
-97.13% Details
9/29/2020 Radius Health RDUS New Coverage Neutral
(N/A)
10.80
(10.08)
-6.67% Details
9/29/2020 BioCryst Pharma BCRX New Coverage Overweight
(N/A)
3.67
(12.60)
243.32% Details
9/29/2020 Immunogen Inc. IMGN New Coverage Neutral
(N/A)
3.58
(4.78)
33.52% Details
9/29/2020 Esperion Therapeutics ESPR New Coverage Underweight
(N/A)
37.12
(6.70)
-81.95% Details
9/29/2020 Stoke Therapeutics STOK New Coverage Neutral
(N/A)
34.93
(12.84)
-63.24% Details
9/29/2020 Mersana MRSN New Coverage Neutral
(N/A)
19.60
(6.76)
-65.51% Details
9/29/2020 Zymeworks ZYME New Coverage Neutral
(N/A)
44.98
(6.15)
-86.33% Details
9/14/2020 Deciphera DCPH New Coverage Neutral
(N/A)
44.87
(18.50)
-58.77% Details
9/14/2020 Nektar Therapeutics NKTR New Coverage Neutral
(N/A)
18.82
(3.20)
-83% Details
9/14/2020 Denali Therapeutics Inc. DNLI New Coverage Overweight
(N/A)
31.99
(30.69)
-4.06% Details
9/14/2020 Arena Pharma ARNA New Coverage Overweight
(N/A)
63.37
(99.98)
57.77% Details
9/14/2020 Halozyme Therapeutics HALO New Coverage Overweight
(N/A)
27.05
(39.54)
46.17% Details
9/14/2020 United Therapeutics Corp. UTHR New Coverage Overweight
(N/A)
102.52
(209.38)
104.23% Details
9/14/2020 Emergent BioSolutions EBS New Coverage Neutral
(N/A)
98.08
(20.99)
-78.6% Details
9/14/2020 Ionis Pharmaceuticals IONS New Coverage Neutral
(N/A)
51.97
(44.23)
-14.89% Details
9/14/2020 Ascendis Pharma ASND New Coverage Overweight
(N/A)
144.70
(103.26)
-28.64% Details
9/14/2020 Jazz Pharmaceuticals JAZZ New Coverage Overweight
(N/A)
136.80
(175.09)
27.99% Details
4/6/2020 Yum! Brands YUM Maintain Neutral
(N/A)
 
 
  Details
1/31/2020 United Therapeutics Corp. UTHR Upgrade Overweight
(Neutral)
96.42
(209.38)
117.15% Details
1/31/2020 Rubius RUBY Downgrade Neutral
(Overweight)
8.05
(0.43)
-94.66% Details
1/31/2020 Intra-Cellular Therapies ITCI Downgrade Neutral
(Overweight)
23.54
(46.53)
97.66% Details
1/31/2020 Arena Pharma ARNA Upgrade Overweight
(Neutral)
44.44
(99.98)
124.98% Details
1/6/2020 Amarin Corporation AMRN New Coverage Neutral
(N/A)
21.53
(1.09)
-94.94% Details
12/9/2019 Zymeworks ZYME New Coverage Neutral
(N/A)
41.92
(6.15)
-85.33% Details
10/28/2019 Aprea APRE New Coverage Neutral
(N/A)
25.70
(0.65)
-97.47% Details
8/13/2019 Aptinyx APTX Downgrade Underweight
(Neutral)
3.53
(0.37)
-89.52% Details
8/9/2019 Nektar Therapeutics NKTR Downgrade Neutral
(Overweight)
29.57
(3.20)
-89.18% Details
3/25/2019 Kaleido Biosciences Inc. KLDO New Coverage Neutral
(N/A)
13.52
(0.29)
-97.86% Details
3/19/2019 Yum! Brands YUM Downgrade Neutral
(Overweight)
100.90
(106.34)
5.39% Details
3/19/2019 Immunogen Inc. IMGN Downgrade Underweight
(Neutral)
2.65
(4.78)
80.38% Details
3/13/2019 Esperion Therapeutics ESPR Upgrade Neutral
(Underweight)
49.81
(6.70)
-86.55% Details
3/11/2019 Mersana MRSN Downgrade Underweight
(Neutral)
4.22
(6.76)
60.19% Details
1/17/2019 Aptinyx APTX Downgrade Neutral
(Overweight)
17.83
(3.53)
-80.2% Details
12/11/2018 Stemline Therapeutics STML New Coverage Overweight
(N/A)
9.98
(11.83)
18.54% Details
11/6/2018 AMAG Pharmaceuticals AMAG Downgrade Underweight
(Neutral)
18.29
(13.75)
-24.82% Details
8/13/2018 Crinetics CRNX New Coverage Neutral
(N/A)
29.84
(19.64)
-34.18% Details
8/13/2018 Rubius RUBY New Coverage Overweight
(N/A)
21.93
(0.43)
-98.04% Details